Humana Past Earnings Performance

Past criteria checks 5/6

Humana has been growing earnings at an average annual rate of 1.6%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 7.3% per year. Humana's return on equity is 8.9%, and it has net margins of 2.6%.

Key information

1.6%

Earnings growth rate

4.2%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate7.3%
Return on equity8.9%
Net Margin2.6%
Next Earnings Update27 Oct 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Humana makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:HUMS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 239,6592501,1760
31 Mar 239,4912321,1220
31 Dec 229,2032101,0820
30 Sep 228,8701831,0370
30 Jun 228,5302039880
31 Mar 228,3472429630
31 Dec 218,1862769260
30 Sep 218,0002938910
30 Jun 217,8962798960
31 Mar 217,8252729020
31 Dec 207,7712629130
30 Sep 207,750230860
30 Jun 207,7392491040
31 Mar 207,6701971130
31 Dec 197,446188890
30 Sep 197,247222-570
30 Jun 197,005196-340
31 Mar 196,774245-210
31 Dec 186,714246250
30 Sep 186,6002282390
30 Jun 186,5501972260
31 Mar 186,5411992180
31 Dec 176,5421942120
30 Sep 176,6351952790
30 Jun 176,6842412870
31 Mar 176,5402262630
31 Dec 166,3621482180
30 Sep 166,1401392880
30 Jun 165,868-112300
31 Mar 165,713-531850
31 Dec 155,593281570
31 Dec 145,065381290
31 Dec 133,489111580
31 Dec 122,982441640

Quality Earnings: HUMS has high quality earnings.

Growing Profit Margin: HUMS's current net profit margins (2.6%) are higher than last year (2.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HUMS's earnings have grown by 1.6% per year over the past 5 years.

Accelerating Growth: HUMS's earnings growth over the past year (23.2%) exceeds its 5-year average (1.6% per year).

Earnings vs Industry: HUMS earnings growth over the past year (23.2%) exceeded the Healthcare industry 3.8%.


Return on Equity

High ROE: HUMS's Return on Equity (8.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/18 05:10
End of Day Share Price 2023/06/21 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Humana AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mikael HolmDanske Bank